FR2809621B1 - USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES SUITABLE AS ANTIDIARRHOISTS - Google Patents

USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES SUITABLE AS ANTIDIARRHOISTS

Info

Publication number
FR2809621B1
FR2809621B1 FR0006178A FR0006178A FR2809621B1 FR 2809621 B1 FR2809621 B1 FR 2809621B1 FR 0006178 A FR0006178 A FR 0006178A FR 0006178 A FR0006178 A FR 0006178A FR 2809621 B1 FR2809621 B1 FR 2809621B1
Authority
FR
France
Prior art keywords
antidiarrhoists
preparation
receptor antagonist
cannabinoid receptor
central cannabinoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0006178A
Other languages
French (fr)
Other versions
FR2809621A1 (en
Inventor
Tiziano Croci
Luciano Manara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to FR0006178A priority Critical patent/FR2809621B1/en
Priority to PCT/FR2001/001432 priority patent/WO2001085092A2/en
Priority to AU2001260406A priority patent/AU2001260406A1/en
Publication of FR2809621A1 publication Critical patent/FR2809621A1/en
Application granted granted Critical
Publication of FR2809621B1 publication Critical patent/FR2809621B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0006178A 2000-05-12 2000-05-12 USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES SUITABLE AS ANTIDIARRHOISTS Expired - Fee Related FR2809621B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0006178A FR2809621B1 (en) 2000-05-12 2000-05-12 USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES SUITABLE AS ANTIDIARRHOISTS
PCT/FR2001/001432 WO2001085092A2 (en) 2000-05-12 2001-05-11 Antidiarrheal cannabinoid cb-1 receptor antagonist
AU2001260406A AU2001260406A1 (en) 2000-05-12 2001-05-11 Antidiarrheal cannabinoid cb-1 receptor antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0006178A FR2809621B1 (en) 2000-05-12 2000-05-12 USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES SUITABLE AS ANTIDIARRHOISTS

Publications (2)

Publication Number Publication Date
FR2809621A1 FR2809621A1 (en) 2001-12-07
FR2809621B1 true FR2809621B1 (en) 2002-09-06

Family

ID=8850242

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0006178A Expired - Fee Related FR2809621B1 (en) 2000-05-12 2000-05-12 USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES SUITABLE AS ANTIDIARRHOISTS

Country Status (3)

Country Link
AU (1) AU2001260406A1 (en)
FR (1) FR2809621B1 (en)
WO (1) WO2001085092A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478183C (en) 2002-03-12 2010-02-16 Merck & Co. Inc. Substituted amides
JP2005528366A (en) 2002-03-26 2005-09-22 メルク　エンド　カムパニー　インコーポレーテッド Spirocyclic amides as cannabinoid receptor modulators
CA2479744A1 (en) 2002-03-28 2003-10-09 Paul E. Finke Substituted 2,3-diphenyl pyridines
AU2003223510B2 (en) 2002-04-12 2008-05-08 Merck Sharp & Dohme Corp. Bicyclic amides
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
US7247628B2 (en) 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7268133B2 (en) 2003-04-23 2007-09-11 Pfizer, Inc. Patent Department Cannabinoid receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7232823B2 (en) 2003-06-09 2007-06-19 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
EP1574211A1 (en) 2004-03-09 2005-09-14 Inserm Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
EA011307B1 (en) 2004-07-12 2009-02-27 Кадила Хелзкэр Лимитед Tricyclic pyrazole derivatives as cannabinoid receptor modulators
US20060025448A1 (en) 2004-07-22 2006-02-02 Cadila Healthcare Limited Hair growth stimulators
WO2007039797A1 (en) * 2005-10-03 2007-04-12 Pfizer Products Inc. Use of cannabinoid receptor-1 antagonist for treating inflammation and arthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (en) * 1993-12-02 1996-03-01 Sanofi Sa Substituted N-piperidino-3-pyrazolecarboxamide.
FR2789079B3 (en) * 1999-02-01 2001-03-02 Sanofi Synthelabo PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Also Published As

Publication number Publication date
WO2001085092A3 (en) 2002-08-29
WO2001085092A2 (en) 2001-11-15
AU2001260406A1 (en) 2001-11-20
FR2809621A1 (en) 2001-12-07

Similar Documents

Publication Publication Date Title
FR2758723B1 (en) USE OF CENTRAL CANNABINOID RECEPTOR ANTAGONISTS FOR THE PREPARATION OF DRUGS
FR2799124B1 (en) USE OF ANTAGONISTS OF CENTRAL CANNABINOID RECEPTORS FOR THE PREPARATION OF DRUGS
FR2809621B1 (en) USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF MEDICINES SUITABLE AS ANTIDIARRHOISTS
FR2804683B1 (en) ORGANOMETALLIC MONOACYLARYLPHOSPHINES, THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF ASYMMETRIC ACYLPHOSPHINES USEFUL AS PHOTO-INHIBITORS
LU92397I2 (en) Vortioxetine or a pharmaceutically acceptable acid addition salt thereof
FR2804959B1 (en) USE OF PAULLON DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS
DZ3347A1 (en) ARYLMETHYLAMINE DERIVATIVES FOR THEIR USE AS TRYPTASE INHIBITORS
HUP0302044A3 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
FR2816908B1 (en) CLUTCH UNIT
HUP0203681A3 (en) Pharmaceutical compositions containing agonists specific for the peripheral cannabinoid receptor and their use
FR2827758B1 (en) ANCILLARY FOR A SPINAL OSTEOSYNTHESIS SYSTEM
HUP0304060A3 (en) Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them
AU2001250205A1 (en) Prostaglandin d2 receptor antagonists
IL157478A0 (en) Method for the synthesis of 2', 3'-didehydronucleosides
PT1009732E (en) 1-AMINO-ALKYLCICLO-HEXANES ANTAGONISTS OF THE NMDA RECEPTOR
IL145334A0 (en) The use of certain affinity nmda antagonists as antidepressants
FR2791405B1 (en) CLUTCH UNIT
FR2807751B1 (en) PROCESS FOR THE PREPARATION OF A HYDRO (CHLORO) FLUOROALCANE AND CATALYST
FR2768447B1 (en) Gantry for limiting the height of a passage
FR2832587B1 (en) SYSTEM FOR TRACKING AND ADDRESSING THE LIGHTS OF A BEACON NETWORK
FR2811998B1 (en) USE OF HETEROXYLANES FOR THE PREPARATION OF FILM-FORMING COMPOSITIONS
FR2723317B1 (en) USE OF NEUROTENSIN ANTAGONISTS FOR THE PREPARATION OF DIURETIC DRUGS
FR2828403B1 (en) USE OF HLA CLASS 1 SOLUBLE MOLECULES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR INHIBITING ANGIOGENESIS
FR2860734B1 (en) PROCESS FOR THE PREPARATION OF A CATALYST, CATALYST AND USE FOR THE COMBUSTION OF SOOT
HUP9902674A2 (en) Use of estrogen agonists/antagonists as a medicament

Legal Events

Date Code Title Description
ST Notification of lapse